<unk>  is a hydrolytic lysosomal glucocerebroside-specific enzyme that is FDA approved for the treatment of type 1 Gaucher disease.   Common adverse reactions include hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, and pyrexia.
Velaglucerase alfa
Taliglucerase alfa
Imiglucerase
Alglucosidase alfa
Vestronidase alfa
Insulin degludec
Insulin aspart
Tiocarlide